Zdrowie i gospodarka · 28/01/1999

FDA Releases Guidance on Electronic NDA Submissions

The Food and Drug Administration (FDA) has made available a guidance document detailing the process for submitting new drug applications (NDAs) in electronic format to the Center for Drug Evaluation and Research (CDER). The agency encourages electronic submissions as a way to improve efficiency, although they are voluntary.